Laura Koskenvuo1, Ari Ristimäki2, Anna Lepistö1. 1. Department of Gastrointestinal Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 2. Research Programs Unit and HUSLAB, Department of Pathology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Abstract
BACKGROUND AND OBJECTIVES: Desmoid-type fibromatosis is a rare disease of which 7.5-16% have been reported to be related to familial adenomatous polyposis (FAP). We sought to compare the characteristics and treatment of sporadic and FAP-related desmoid-type fibromatoses. METHODS: Altogether 220 patients were included in the study after receiving a diagnosis of desmoid-type fibromatosis by the Pathology Department of Helsinki University Hospital, with adequate follow-up. Patients were included from January 1, 1980 until April 30, 2015. RESULTS: FAP-related tumors were found in 22 (10%) patients. FAP-related desmoid-type fibromatoses were larger, more commonly multiple, and more often intra-abdominally situated. Surgery was the treatment of choice for 179 (90%) of the sporadic patients and for 18 (82%) of FAP-related patients. Resections with non-involved margins (R0) were more common in sporadic desmoid-type fibromatoses (55% vs. 23%, P = 0.048). The risk of recurrence was 25% in sporadic- and 44% in the FAP-related group. Three (14%) patients with FAP-related desmoid-type fibromatoses died from the disease. CONCLUSIONS: The predictors for FAP occurrence among desmoid tumor patients are large tumor size, intra-abdominal location, multiple tumors, and patient's young age. Desmoid-type fibromatosis patients suffer a high recurrence rate, also among those experiencing sporadic tumors, but the risk of death due to the tumor is low. Conversely, desmoid disease represents a substantial cause of death among FAP patients.
BACKGROUND AND OBJECTIVES:Desmoid-type fibromatosis is a rare disease of which 7.5-16% have been reported to be related to familial adenomatous polyposis (FAP). We sought to compare the characteristics and treatment of sporadic and FAP-related desmoid-type fibromatoses. METHODS: Altogether 220 patients were included in the study after receiving a diagnosis of desmoid-type fibromatosis by the Pathology Department of Helsinki University Hospital, with adequate follow-up. Patients were included from January 1, 1980 until April 30, 2015. RESULTS: FAP-related tumors were found in 22 (10%) patients. FAP-related desmoid-type fibromatoses were larger, more commonly multiple, and more often intra-abdominally situated. Surgery was the treatment of choice for 179 (90%) of the sporadic patients and for 18 (82%) of FAP-related patients. Resections with non-involved margins (R0) were more common in sporadic desmoid-type fibromatoses (55% vs. 23%, P = 0.048). The risk of recurrence was 25% in sporadic- and 44% in the FAP-related group. Three (14%) patients with FAP-related desmoid-type fibromatoses died from the disease. CONCLUSIONS: The predictors for FAP occurrence among desmoid tumorpatients are large tumor size, intra-abdominal location, multiple tumors, and patient's young age. Desmoid-type fibromatosispatients suffer a high recurrence rate, also among those experiencing sporadic tumors, but the risk of death due to the tumor is low. Conversely, desmoid disease represents a substantial cause of death among FAP patients.
Authors: Sai Ge; Duo Cheng; Xuhui Zhang; Ting Xu; Zhenghang Wang; Fengxiao Dong; Lan Su; Jinlei Song; Jia Wang; Jian Li; Lin Shen; Xicheng Wang Journal: Am J Cancer Res Date: 2022-09-15 Impact factor: 5.942
Authors: E Cojocaru; S Gennatas; K Thway; C Fisher; A Smrke; D Strauss; A Hayes; M Smith; R L Jones; C Benson; T P McVeigh Journal: Fam Cancer Date: 2021-02-06 Impact factor: 2.375
Authors: K Seidensaal; S B Harrabi; F Weykamp; K Herfarth; T Welzel; G Mechtersheimer; B Lehner; M Schneider; S Fröhling; G Egerer; J Debus; M Uhl Journal: Radiat Oncol Date: 2020-06-05 Impact factor: 3.481
Authors: Alexcia C Braun; Fernando A B Campos; Emne A Abdallah; Anna P C Ruano; Tiago da S Medina; Milena S Tariki; Fabio F E Pinto; Celso A L de Mello; Ludmilla T D Chinen Journal: Front Oncol Date: 2021-09-14 Impact factor: 6.244